Skip to main content
Clinical Trials/CTRI/2020/09/027693
CTRI/2020/09/027693Not yet recruitingPhase 1

Efficacy Of Nimbalodhra Kwatha Seka In The Management Of Vataja Abhishyanda W.S.R To Simple Allergic Conjunctivitis A Randomized Controlled Clinical Trial

Dr Prathibha Prakash0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients presenting with signs and symptoms of clinically established Vataja Abhishyanda and fulfilling the diagnostic criteria
  • Patients with age group of 12 to 60yrs
  • Patients of either sex

Exclusion Criteria

  • Patients suffering from vernal Kerato conjunctivitis Atopic Kerato conjunctivitis Giant papillary conjunctivitis.
  • Patients having complicated eye diseases, Trachoma, Chalazion, Stye, Pterygium, Dacryocystitis, Trichiasis, etc.
  • Patients suffering from Corneal Opacity, Ulcers.
  • Diagnosed cases of Glaucoma and any ophthalmic infective conditions will be excluded.
  • Patients with other systemic disorders like renal diseases, uncontrolled hyperglycemia and hyperlipidemia, cardiovascular diseases etc will be excluded.
  • Extremely debilitated patients and in pregnancy.

Investigators

Sponsor
Dr Prathibha Prakash

Similar Trials